GenSight Biologics SA's total assets for Q2 2024 were €14.99M, an increase of 64.10% from the previous quarter. FR:SIGHT total liabilities were €39.82M for the fiscal quarter, a 0.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.